Correlation of FAZA PET Hypoxia Imaging To 3D Histology in Oral Tongue Cancer (FAITH)
Defining a Personalized Hypoxic Radiation Target Through Correlation of Functional F18-FAZA PET Imaging to Pimonidazole-stained 3D Whole-mounted Histological Specimen
Sponsor: Sunnybrook Health Sciences Centre
Suspended
Pause to enrolment due to COVID-19 pandemic and protocol amendment (change to equipment used)
This PHASE1/PHASE2 trial investigates Tongue Cancer and is currently suspended. Sunnybrook Health Sciences Centre leads this study, which shows 10 recorded versions since 2018 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Suspended PHASE1/PHASE2
Status: Recruiting → Suspended
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Recruiting PHASE1_PHASE2
-
Nov 2021 — Jan 2023 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2021 — Nov 2021 [monthly]
Recruiting PHASE1_PHASE2
▶ Show 5 earlier versions
-
Aug 2020 — Jan 2021 [monthly]
Recruiting PHASE1_PHASE2
-
May 2019 — Aug 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Jun 2018 — May 2019 [monthly]
Recruiting PHASE1_PHASE2
-
May 2018 — Jun 2018 [monthly]
Recruiting PHASE1_PHASE2
Status: Not Yet Recruiting → Recruiting
-
Jun 2017 — May 2018 [monthly]
Not Yet Recruiting PHASE1_PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Sunnybrook Health Sciences Centre
- Sunnybrook Research Institute
- University of Toronto
For direct contact, visit the study record on ClinicalTrials.gov .